Top Markets
#1 DeFiChain DeFiChain +2,516.54%
#2 Akedo Akedo +207.46%
#3 ONFA ONFA +54.25%
#4 Metaplex Metaplex +23.40%
#5 Osaka Protocol Osaka Protocol +21.54%
#6 Wrapped Krown Wrapped Krown +20.00%
#7 Talus Network Talus Network +19.98%
#8 DODO DODO +17.78%
#9 Black Phoenix Black Phoenix +15.09%
#10 Magma Finance Magma Finance +14.74%
Coin of the day
DeFiChain DeFiChain
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Valbiotis SA Valbiotis SA

Valbiotis SA

ALVAL
Classement en actions #16315
Valbiotis SA engages in the research and development of health nutrition... Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.
Prix de l'action
$0.94180721
Capitalisation boursière
$22.26M
Changement (1 jour)
0.38%
Changement (1 an)
-14.35%
Pays
FR
Échange Valbiotis SA (ALVAL)

Catégorie

Healthcare
EPS pour Valbiotis SA (ALVAL)
EPS au December 2025 TTM : $-0.57
Selon les derniers rapports financiers et le cours de l'action de Valbiotis SA, l’EPS actuel de la société (TTM) est de $-0.57. À la fin de 2023, la société avait un EPS de $-0.65 une diminution par rapport à celui de 2022, qui était de $-1.31.
Historique de l'EPS de Valbiotis SA de 2015 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $-0.57 -12.89%
2024 $-0.66 0.52%
2023 $-0.65 -50.16%
2022 $-1.31 21.14%
2021 $-1.08 73.93%
2020 $-0.62 -52.69%
2019 $-1.31 -13.46%
2018 $-1.52 37.41%
2017 $-1.10 517.05%
2016 $-0.18 -99.73%
2015 $-65.94 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $4.36 -858.10%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.01 -3,058.78%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $42.53 -7,497.81%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $9.62 -1,773.47%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $23.88 -4,253.77%
NL